According to AIER Eye Hospital's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 41.825. At the end of 2022 the company had a P/E ratio of 112.
Year | P/E ratio | Change |
---|---|---|
2022 | 112 | 0.48% |
2021 | 111 | -36.98% |
2020 | 177 | 99.16% |
2019 | 88.7 | 52.86% |
2018 | 58.0 | -8.7% |
2017 | 63.6 | 17.61% |
2016 | 54.1 | -24.73% |
2015 | 71.8 | 25.03% |
2014 | 57.4 | -2.35% |
2013 | 58.8 | 45.15% |
2012 | 40.5 | -33.45% |
2011 | 60.9 | -39.47% |
2010 | 101 | 81.3% |
2009 | 55.5 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.